BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17466918)

  • 1. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
    Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
    Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of MIP-3alpha gene to the tumor following radiation therapy boosts anti-tumor immunity in a murine model of lung carcinoma.
    Zhu B; Zou L; Cheng X; Lin Z; Duan Y; Wu Y; Zhou F; Chen Z
    Immunol Lett; 2006 Mar; 103(2):101-7. PubMed ID: 16257060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells.
    Luo X; Yu Y; Liang A; Xie Y; Liu S; Guo J; Wang W; Qi R; An H; Zhang M; Xu H; Guo Z; Cao X
    Cell Mol Immunol; 2004 Jun; 1(3):199-204. PubMed ID: 16219168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
    Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
    Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity.
    Crittenden M; Gough M; Harrington K; Olivier K; Thompson J; Vile RG
    Cancer Res; 2003 Sep; 63(17):5505-12. PubMed ID: 14500387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenoviral gene transfer of stromal cell-derived factor-1 to murine tumors induces the accumulation of dendritic cells and suppresses tumor growth.
    Fushimi T; O'Connor TP; Crystal RG
    Cancer Res; 2006 Apr; 66(7):3513-22. PubMed ID: 16585175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-18 gene-modified dendritic cells].
    Chen J; Cao X; Xiu Q
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):779-82. PubMed ID: 11798964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
    Jin GH; Hirano T; Murakami M
    Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.
    Machlenkin A; Goldberger O; Tirosh B; Paz A; Volovitz I; Bar-Haim E; Lee SH; Vadai E; Tzehoval E; Eisenbach L
    Clin Cancer Res; 2005 Jul; 11(13):4955-61. PubMed ID: 16000595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model.
    Pender SL; Chance V; Whiting CV; Buckley M; Edwards M; Pettipher R; MacDonald TT
    Gut; 2005 Aug; 54(8):1114-20. PubMed ID: 16009684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pivotal role for CC chemokine receptor 5 in T-cell migration to tumor sites induced by interleukin 12 treatment in tumor-bearing mice.
    Uekusa Y; Yu WG; Mukai T; Gao P; Yamaguchi N; Murai M; Matsushima K; Obika S; Imanishi T; Higashibata Y; Nomura S; Kitamura Y; Fujiwara H; Hamaoka T
    Cancer Res; 2002 Jul; 62(13):3751-8. PubMed ID: 12097285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
    Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
    J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
    Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
    J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta.
    Tedla N; Wang HW; McNeil HP; Di Girolamo N; Hampartzoumian T; Wakefield D; Lloyd A
    J Immunol; 1998 Nov; 161(10):5663-72. PubMed ID: 9820547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
    Chandy AG; Nurkkala M; Josefsson A; Eriksson K
    Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infiltrating neutrophils induce allospecific CTL in response to immunization with apoptotic cells via MCP-1 production.
    Shiratsuchi Y; Iyoda T; Tanimoto N; Kegai D; Nagata K; Kobayashi Y
    J Leukoc Biol; 2007 Feb; 81(2):412-20. PubMed ID: 17095610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoral immune response by recruitment and expansion of dendritic cells in tumors infected with telomerase-dependent oncolytic viruses.
    Edukulla R; Woller N; Mundt B; Knocke S; Gürlevik E; Saborowski M; Malek N; Manns MP; Wirth T; Kühnel F; Kubicka S
    Cancer Res; 2009 Feb; 69(4):1448-58. PubMed ID: 19190348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained and NK/CD4+ T cell-dependent efficient prevention of lung metastasis induced by dendritic cells harboring recombinant Sendai virus.
    Komaru A; Ueda Y; Furuya A; Tanaka S; Yoshida K; Kato T; Kinoh H; Harada Y; Suzuki H; Inoue M; Hasegawa M; Ichikawa T; Yonemitsu Y
    J Immunol; 2009 Oct; 183(7):4211-9. PubMed ID: 19734206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tick saliva inhibits the chemotactic function of MIP-1alpha and selectively impairs chemotaxis of immature dendritic cells by down-regulating cell-surface CCR5.
    Oliveira CJ; Cavassani KA; Moré DD; Garlet GP; Aliberti JC; Silva JS; Ferreira BR
    Int J Parasitol; 2008 May; 38(6):705-16. PubMed ID: 18023445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.